The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma

Abstract

Background and purpose Hypoxia and proliferation are important determinants of radiation responsiveness; prospective measures of these before radiotherapy may enable individualisation of treatment schedules. Immunohistochemical techniques offer a potential means of achieving this in routine biopsy material. Material and methods Cellular hypoxia as measured by pimonidazole fixation and immunohistochemistry has been evaluated in a series of human bladder cancers with dual staining of sections for pimonidazole and either the vascular markers, CD31/34, or proliferation markers, Ki-67 or cyclin A. Twenty one tumour specimens were examined suitable for the double staining technique. Results The median hypoxic fraction was 9% (range 0–38). Seven tumours did not stain for pimonidazole and 11 exhibited necrosis. The mean vascular density ranged from 16.7 to 160.6 vessels per mm 2. The median hot spot count was 30 (range 16–43). There was a statistically significant increase in vessel density in hypoxic compared to oxic regions measured by both vessel density ( P=0.02) and hot spot count ( P=0.004). Proliferation indices decreased from oxic to hypoxic areas close to blood vessels. Conclusions We have demonstrated that bladder cancer exhibits a range of hypoxia, proliferation and vascular density which may be used to form the basis for patient selection for hypoxia modification, accelerated radiotherapy and vascular targeting agents.